China bak battery launches the first automated lithium-ion production line for laptop batteries in china

China BAK Battery Launches The First Automated Lithium-ion Production Line for Laptop Batteries in China SHENZHEN, China, July 20 /Xinhua-PRNewswire/ -- China BAK Battery, Inc. (Nasdaq: of the largest Li-ion battery cell manufacturer in China and the world, announced today that it has successfully launched the first automated cylindrical, lithium-ion battery cell production line. The newly-launched production line employs advanced technologies and automation for the manufacture of consistently high-quality cylindrical battery cells for notebook computers. "Our monthly production capacity has reached two million units, and we believe we are one of the first manufacturers with an automated production line for cylindrical, lithium-ion battery cells in China," said Xiangqian Li, China BAK's Chief Executive Officer. "We believe this will position us to capture opportunities in the global notebook computer battery market." China BAK Battery develops and manufactures laptop batteries with energy densities of 500wh/L or higher and an average product life span of more than two years, which it believes, meets or surpasses the performance standards of battery cells of leading manufacturers in Korea and Japan. These notebook battery cells are designed to high safety standards from the thermological, electrical and mechanical perspectives. China BAK applies stringent control in materials selection and processing, and has obtained UL, RoHS and other certifications for its notebook battery cell This press release contains forward-looking statements, which are subject to change. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All "forward-looking statements" relating to the business of China BAK Battery, Inc. and its subsidiary companies, which can be identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involve known and unknown risks and uncertainties which could cause actual results to differ. These factors include but are not limited to: risks related to our business and risks related to operating in China. Please refer to our 10-K for specific details on our risk factors. China BAK Battery, Inc. is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events or otherwise. China BAK Battery, Inc. is one of the largest manufacturers of lithium-based battery cells in China and the world. It produces battery cells that are the principal component of rechargeable batteries commonly used to power cellular phones, notebook computers, cordless power tools and portable consumer electronics, such as digital media devices, portable media players, portable audio players, portable gaming devices, PDAs and Blackberries. BAK's 1.9 million square feet facilities are located in Shenzhen, PRC, and have been recently expanded to produce new products. BAK has the largest share of the lithium-ion cellular phone replacement battery market in China.

Source: http://www.bak.com.cn/Upload/%E5%85%AC%E5%8F%B8%E6%96%B0%E9%97%BB/%E8%8B%B1%E6%96%87/2006/2006722-01004179897.pdf

Prozacforpets

Press Release FOR IMMEDIATE RELEASE FDA Approved Prozac for Pets Does Not Include Mandatory ANH-USA submits Citizen Petition to require increased risk of violence warning label be included on all versions of the drug August 16, 2010 (Washington, DC ) — The FDA has approved a reformulated version of the much-prescribed SSRI antidepressant (selective serotonin reuptake inhibi

thedentons.us

EDITORIAL Secondary Prevention After Coronary Bypass: The American Heart Association “Get With the Guidelines” Program Timothy A. Denton, MD, Gregg C. Fonarow, MD, Kenneth A. LaBresh, MD, and Alfredo Trento, MD Divisions of Cardiology and Cardiothoracic Surgery, Cedars-Sinai Medical Center, Los Angeles, California, Division of Cardiology, University of California Los Angeles School of M

Copyright © 2018 Medical Abstracts